D-Mannose Market is Poised to reach US$ XX Bn by 2025, Due to Presence of Widespread Population Demographics Suffering from UTI

D-Mannose Market is Poised to reach US$ XX Bn by 2025, Due to Presence of Widespread Population Demographics Suffering from UTI

“The D-Mannose Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to the presence of widespread population demographics suffering from UTI.

Precision Business Insights (PBI) in its report titled “D Mannose Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Request Sample: https://precisionbusinessinsights.com/request-sample?product_id=23041

The d-mannose market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Bn by 2025. Rising awareness regarding the benefits of d-mannose in the treatment of various diseases is anticipated to fuel the d-mannose market. The growing prevalence of antibiotic resistance with regard to several key pathogens has thus been helpful for alternatives such as the global d-mannose market. However, stringent government policies for the approval of the product might hinder its growth in the forecast period.

D-mannose market segmented on the basis of product type, application, and distribution channel.

Capsule Segment Expected to Dominate the Market

On the basis of product type, the d-mannose market is segmented into capsules, powder, and tablets. Capsules are likely to remain the dominant contributor to the global d-mannose market in the coming years. The capsules segment is likely to consistently account for more than XX% of the global d-mannose market though the 2019-2025 forecast period and reach a valuation of US $ XX Mn by the end of 2025. The growth of the capsules segment through the forecast period also represents the highest CAGR of all product segments of the global d-mannose market, with the segment likely to exhibit a steady XX% CAGR.

Indirect Distribution Will Dominate the Revenue Share.

By distribution channel, d-mannose market is segmented into direct and indirect distribution channels. The indirect distribution channel is further sub-segmented into online retail, pharmacies, and specialty drug stores. The indirect distribution channel is expected to account for most of the market share in this segment due to the increasing utilization of D-mannose as a finished product.

North America & Europe, Accounts for Major Revenue Share for D-Mannose Market

Precision Business Insights (PBI) d-mannose market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, d-mannose market in North America and Europe is expected to dominate global figures over the forecast period, followed by Asia Pacific. Increase in the number of local players in Asia Pacific is anticipated to entail higher procurement of d-mannose products in the region. Asia Pacific is expected to become a prominent player in the global d-mannose market by the end of the forecast period, with the region’s significant CAGR attributed to the steady growth of the nutraceuticals and animal feed industries in the region.

Ask Analyst:
https://precisionbusinessinsights.com/market-reports/d-mannose-market/#ulp-4H8Z4LpNMLEuOnnx

New Product Launch Play Vital Role in D Mannose Market

Key players have placed central focus on expansion of their manufacturing facilities, while attempting to acquire local players in developing markets. For instance, March 2017: Jarrow Formulas has launched an all new D-Mannose and Organic Cranberry powder.
Some of the key players mentioned in the report are VWR Corporation, Atrium Innovations Inc., Ferro Pfanstiehl Laboratories, Inc., Now Health Group Incorporation, Hänseler AG, and Kyowa Hakko Kirin Co Ltd, E. I. du Pont de Nemours and Company, Bio-Tech Pharmacal Inc., Jarrow Formulas Inc., and Nutraceutical International Corporation.

Detailed Segmentation

By Product Type

o Powder
o Capsules
o Tablets

By Application Type

o Pharmaceuticals
o Animal Feed
o Dietary Supplement
o Others

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

Full Study: https://precisionbusinessinsights.com/market-reports/d-mannose-market/

Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

This release was published on openPR.